Thanks to Titans and IndexInvestor and sorry for the confusion on Q2
I was trying to get a brief idea on their current active product and possible timeframe by going through their recent announcements and the website
FXS is pending for IND submission in the current quarter
XanaMia and FX are both in study/pre clinical stage, Mia started in July and FX is expected starting from Dec
SAD and MAD are the long term study on healthy people started from 2013 and 2015 respectively
XanaDu was failed
XanaHES looks like has failed too as too much dose?
So my understanding is no clinical trial is undergoing currently but FXS is closed to IND approval for phase 1 trial. Please enlighten me what I have missed. Much appreciated!
Thanks to Titans and IndexInvestor and sorry for the confusion...
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
-0.001(3.85%) |
Mkt cap ! $77.06M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.7¢ | 2.5¢ | $83.82K | 3.202M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 1220105 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 768793 | 4 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| ACW (ASX) Chart |